ONC vs ROIV
BeOne Medicines AG · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | ONC | ROIV |
|---|---|---|
| Price | $361.65 | $35.78 |
| Market Cap | $534.56B | $25.84B |
| P/E | 1863.03 | — |
| P/B | 103.32 | 6.11 |
| P/S | 100.05 | 3128.90 |
| ROE | 5.5% | -7.1% |
| Net Margin | 5.4% | -3629.2% |
| Gross Margin | 87.5% | — |
| Revenue Growth | 40.2% | -71.6% |
| Dividend Yield | — | — |
| EPS | $0.19 | -$0.42 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.